AVTX
#2622
Avalo Therapeutics, Inc. - Common Stock
13.2 4 USD
-0.03%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-3.00%
Monatliche Änderung
-19.42%
6 month change
-2.36%
Jahresänderung
-2.58%
Vorheriger Schlusskurs
13.6 5
Open
13.5 6
Tief
13.1 3
Hoch
13.6 9
Financials
2021
Current report, 17 Mar 2021
Avalo Therapeutics, Inc. current report, 17 March 2021
8-K
Current report, 08 Mar 2021
Avalo Therapeutics, Inc. current report, 08 March 2021
8-K
Current report, 01 Mar 2021
Avalo Therapeutics, Inc. current report, 01 March 2021
8-K
Current report, 07 Jan 2021
Avalo Therapeutics, Inc. current report, 07 January 2021
8-K
Current report, 07 Jan 2021
Avalo Therapeutics, Inc. current report, 07 January 2021
8-K
Current report, 05 Jan 2021
Avalo Therapeutics, Inc. current report, 05 January 2021
8-K
2020
Annual report, FY2020
Avalo Therapeutics, Inc. annual report, FY2020
10-K
Current report, 16 Nov 2020
Avalo Therapeutics, Inc. current report, 16 November 2020
8-K
Current report, 09 Nov 2020
Avalo Therapeutics, Inc. current report, 09 November 2020
8-K
Current report, 08 Oct 2020
Avalo Therapeutics, Inc. current report, 08 October 2020
8-K